Skin Grafting
SOC → SCF-DBI Logic Translation
Purpose
Skin Grafting is a reconstructive procedure involving transplantation of viable skin tissue onto a prepared wound bed to restore barrier function, facilitate wound closure, reduce infection risk, and preserve long-term tissue function.
Skin grafting may include:
- Split-thickness skin grafting (STSG)
- Full-thickness skin grafting (FTSG)
- Sheet grafting
- Meshed grafting
- Stamp grafting
- Cultured epithelial autografting
- Composite skin substitutes
- Staged graft reconstruction
Under SCF-DBI, Skin Grafting is not merely coverage of a wound.
It is restoration of the Cutaneous Integration and Barrier Restoration Network (CIBRN) through coordinated graft incorporation, immune regulation, microvascular adaptation, and functional skin regeneration.
SOC Definition
Clinical Objective
Provide durable wound coverage to:
- Restore epidermal barrier integrity
- Reduce evaporative losses
- Prevent infection
- Promote wound closure
- Preserve function
- Improve cosmetic outcomes
- Facilitate rehabilitation
- Minimize scar-related disability
Applicable Conditions
Burn Reconstruction
Examples:
- Deep partial-thickness burns
- Full-thickness burns
- Early excision and grafting protocols
- Large TBSA burns
Traumatic Soft-Tissue Defects
Examples:
- Degloving injuries
- Abrasions with tissue loss
- Post-debridement wounds
Chronic Wounds
Examples:
- Non-healing ulcers
- Complex postoperative wounds
- Granulating defects
Oncologic Reconstruction
Examples:
- Post-tumor excision defects
- Dermatologic oncologic defects
Salvage Reconstruction
Examples:
- Flap donor-site closure
- Revision grafting
- Failed previous graft reconstruction
SCF-DBI Translation
Core Concept
SOC views Skin Grafting as:
Transplantation of skin tissue to achieve wound closure.
SCF-DBI views Skin Grafting as:
Restoration of the Cutaneous Integration and Barrier Restoration Network through biologic integration of transplanted tissue into a regenerative wound environment.
The objective extends beyond wound coverage.
The objective is preservation and restoration of:
- Barrier integrity
- Microvascular integration
- Immune equilibrium
- Functional skin quality
- Infection resistance
- Long-term tissue resilience
SCF-DBI Cutaneous Failure Architecture
Domain 1
Cutaneous Integration Failure
SOC Focus
Achieve graft take.
SCF-DBI Focus
Restore integrated biologic systems necessary for durable skin regeneration.
Failure Cascade
Skin loss
↓
Barrier disruption
↓
Fluid loss
↓
Microbial exposure
↓
Inflammatory amplification
↓
Impaired wound-bed support
↓
Graft failure
↓
Delayed healing
↓
Functional impairment
SCF Classification
Cutaneous Integration Failure Syndrome (CIFS)
A state in which disruption of barrier function and regenerative support compromises successful graft incorporation.
Output
Cutaneous Severity Score (CSS)
Domain 2
Graft Integration and Infection Prediction
Major SCF-DBI Enhancement
Selected Enhancement:
Graft Integration and Infection Prediction (GIIP)
This becomes the principal SCF-DBI enhancement for Skin Grafting.
Rationale
SOC evaluates:
- Percentage graft take
- Presence of hematoma
- Seroma formation
- Clinical evidence of infection
SCF-DBI evaluates:
Whether graft incorporation is progressing toward durable regenerative integration or toward biologic failure.
The central question becomes:
Is the graft transitioning into a functional component of the host integumentary system while resisting infectious disruption?
Failure Cascade
Poor wound-bed support
↓
Microvascular insufficiency
↓
Bacterial colonization
↓
Inflammatory persistence
↓
Graft separation
↓
Partial graft loss
↓
Complete graft failure
↓
Delayed closure
Recovery Cascade
Prepared wound bed
↓
Plasmatic imbibition
↓
Inosculation
↓
Microvascular integration
↓
Immune stabilization
↓
Barrier restoration
↓
Graft maturation
↓
Functional recovery
Assessment Domains
Domain | Function |
Graft adherence | Integration quality |
Percentage graft take | Regenerative success |
Infection surveillance | Biologic safety |
Exudate characteristics | Wound environment |
Hematoma/seroma presence | Mechanical support |
Tissue maturation | Long-term incorporation |
Integration States
State | Interpretation |
Green | Successful graft integration |
Yellow | Delayed incorporation |
Orange | Significant compromise |
Red | Progressive graft failure |
Output
Graft Integration and Infection Prediction Score (GIIPS)
Domain 3
Microvascular Incorporation Intelligence
SCF-DBI Enhancement
Early graft survival depends upon restoration of vascular continuity.
Assessment Domains
Domain | Function |
Plasmatic imbibition progression | Initial viability |
Inosculation success | Vascular linkage |
Capillary integration | Perfusion support |
Tissue oxygenation | Cellular viability |
Uniform perfusion | Healing efficiency |
Output
Microvascular Incorporation Score (MIS)
Domain 4
Barrier Restoration Surveillance
SCF-DBI Enhancement
The skin functions as the body’s primary protective interface.
Assessment Domains
Domain | Function |
Fluid-loss control | Barrier competence |
Infection resistance | Protective function |
Epidermal continuity | Structural recovery |
Moisture balance | Physiologic stability |
Local tissue integrity | Regenerative quality |
Output
Barrier Restoration Score (BRS-SG)
Domain 5
Scar Modulation Intelligence
SCF-DBI Enhancement
Long-term outcomes depend upon regulation of scar formation.
Assessment Domains
Domain | Function |
Scar thickness | Fibrotic burden |
Pigment adaptation | Cosmetic recovery |
Tissue elasticity | Functional quality |
Contracture potential | Mobility preservation |
Hypertrophic progression | Remodeling trajectory |
Risk States
State | Interpretation |
Green | Favorable remodeling |
Yellow | Mild scar amplification |
Orange | Significant scar burden |
Red | Progressive hypertrophic contracture trajectory |
Output
Scar Modulation Score (SMS)
Domain 6
Functional Skin Reintegration
SCF-DBI Enhancement
The endpoint of grafting is restoration of meaningful skin function.
Assessment Domains
Domain | Function |
Joint mobility preservation | Functional independence |
Sensory adaptation | Cutaneous recovery |
Cosmetic acceptability | Psychosocial integration |
Rehabilitation participation | Recovery progression |
Activities of daily living | Long-term resilience |
Reintegration States
State | Interpretation |
Green | Functional reintegration progressing |
Yellow | Delayed adaptation |
Orange | Significant functional limitation |
Red | Persistent disability risk |
Output
Functional Skin Reintegration Score (FSRS-SG)
Domain 7
RHENOVA Cutaneous Recovery Matrix
SCF-DBI Enhancement
The objective is durable restoration of a functional, resilient skin interface.
Recovery Domains
Regenerative Recovery
Domain | Function |
Graft incorporation | Tissue restoration |
Microvascular adaptation | Viability support |
Barrier Recovery
Domain | Function |
Infection resistance | Protective integrity |
Fluid regulation | Homeostatic function |
Functional Recovery
Domain | Function |
Mobility preservation | Independence |
Cosmetic adaptation | Long-term resilience |
Output
RHENOVA Cutaneous Recovery Score (RCRS)
RHENOVA Integration
R1 — Survival Preservation
Prevent:
- Graft loss
- Wound sepsis
- Persistent barrier failure
Output:
Cutaneous Rescue Status
R2 — Recovery Optimization
Restore:
- Graft integration
- Barrier competence
- Microvascular continuity
Output:
Recovery Readiness Score
R3 — Regenerative Preservation
Protect:
- Cutaneous architecture
- Capillary interfaces
- Native regenerative potential
Output:
Cutaneous Regeneration Profile
R4 — Functional Restoration
Achieve:
- Durable wound closure
- Functional skin performance
- Rehabilitation progression
Output:
Cutaneous Restoration Matrix
R5 — Long-Term Resilience
Prevent:
- Graft failure
- Chronic wound recurrence
- Hypertrophic scarring
- Contracture formation
- Functional decline
Output:
Cutaneous Resilience Profile
SCF-DBI Skin Grafting Workflow
Step 1
Identify Cutaneous Integration Failure.
Output
Cutaneous Severity Score.
Step 2
Perform skin graft harvesting and graft application.
Output
Cutaneous Integration and Barrier Restoration Network Restoration Confirmation.
Step 3
Activate Graft Integration and Infection Prediction.
Output
Graft Integration and Infection Prediction Score.
Step 4
Assess microvascular incorporation.
Output
Microvascular Incorporation Score.
Step 5
Evaluate barrier restoration.
Output
Barrier Restoration Score.
Step 6
Assess scar modulation trajectory.
Output
Scar Modulation Score.
Step 7
Determine functional skin reintegration.
Output
Functional Skin Reintegration Score.
Step 8
Generate the RHENOVA Cutaneous Recovery Matrix.
Output
RHENOVA Cutaneous Recovery Score.
Glossary
Term | Definition |
Skin Grafting | Transplantation of skin tissue to restore wound coverage and barrier function. |
Cutaneous Integration and Barrier Restoration Network (CIBRN) | SCF-DBI model describing integrated regenerative, immune, vascular, and functional systems governing graft success. |
Cutaneous Integration Failure Syndrome (CIFS) | SCF-DBI classification describing failure of graft incorporation and barrier restoration. |
Graft Integration and Infection Prediction (GIIP) | Primary SCF-DBI framework evaluating graft incorporation and infectious disruption risk. |
Graft Integration and Infection Prediction Score (GIIPS) | Composite measure of successful graft maturation versus failure trajectory. |
Microvascular Incorporation Score (MIS) | Assessment of vascular integration and perfusion restoration. |
Barrier Restoration Score (BRS-SG) | Evaluation of recovery of protective skin function. |
Scar Modulation Score (SMS) | Assessment of fibrotic remodeling and contracture risk. |
Functional Skin Reintegration Score (FSRS-SG) | Evaluation of restoration of mobility, sensory adaptation, and functional performance. |
RHENOVA Cutaneous Recovery Score (RCRS) | Integrated measure of graft integration, barrier restoration, and long-term cutaneous resilience. |
SCF Principle Alignment
SCF Principle | Skin Grafting Application |
Targeted Action | Restoration of cutaneous defects through biologically integrated tissue replacement |
Pharmacokinetic Optimization | Enhancement of graft perfusion, nutrient delivery, and vascular incorporation |
Metabolic Efficiency | Preservation of regenerative substrates while minimizing inflammatory burden |
Resistance Prevention | Prevention of graft infection, graft loss, hypertrophic scarring, and contracture formation |
Safety Profile | Continuous surveillance of graft integration, infection risk, scar modulation, and functional recovery |
INDEX
SCF-BURN-SKIN-GRAFTING-0001
SCF-DBI-CUTANEOUS-INTEGRATION-AND-BARRIER-RESTORATION-NETWORK-0001
SCF-DBI-CUTANEOUS-INTEGRATION-FAILURE-SYNDROME-0001
SCF-DBI-GRAFT-INTEGRATION-AND-INFECTION-PREDICTION-0001
SCF-DBI-GRAFT-INTEGRATION-AND-INFECTION-PREDICTION-SCORE-0001
SCF-DBI-MICROVASCULAR-INCORPORATION-SCORE-0001
SCF-DBI-BARRIER-RESTORATION-SCORE-SG-0001
SCF-DBI-SCAR-MODULATION-SCORE-0001
SCF-DBI-FUNCTIONAL-SKIN-REINTEGRATION-SCORE-SG-0001
SCF-DBI-RHENOVA-CUTANEOUS-RECOVERY-MATRIX-0001
SCF-SKIN-GRAFTING-WORKFLOW-0076
SCF-SKIN-GRAFTING-MASTER-0001